Apollo Hospitals Enterprise Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
7078.20 -61.70 (-0.86%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
7059.15
Today’s High
7130.5
52 Week Low
4727
52 Week High
7319.95
7071.30 -68.85 (-0.96%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
7056
Today’s High
7135.2
52 Week Low
4726
52 Week High
7316.95
Key Metrics
- Market Cap (In Cr) 102664.4
- Beta 1.01
- Div. Yield (%) 0.22
- P/B 14.8
- TTM P/E 85.74
- Peg Ratio 2.4
- Sector P/E 29.87
- D/E -
- Open Price 7120
- Prev Close 7139.9
Apollo Hospitals Enterprise Analysis
Price Analysis
-
1 Week3.12%
-
3 Months10.64%
-
6 Month12.71%
-
YTD25.18%
-
1 Year42.19%
Risk Meter
- 20% Low risk
- 20% Moderate risk
- 20% Balanced Risk
- 20% High risk
- 20% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 6
- 6
- 6
- 6
- Buy
- 13
- 13
- 13
- 16
- Hold
- 3
- 3
- 3
- 1
- Sell
- 2
- 2
- 2
- 1
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 24
- 24
- 24
- 24
Apollo Hospitals Enterprise News
Stocks to Watch: IDFC First Bank, PNB, Dr Reddy's, REC, RIL, Welspun and more
2 min read . 30 Sep 2024Adani Enterprises, Tata Motors and more: These 5 stocks posted over 45% jump in Q1 PAT
4 min read . 16 Aug 2024Apollo Hospitals Enterprise Q1 Results Live : profit rise by 83.19% YOY
1 min read . 14 Aug 2024Apollo Hospitals Enterprise Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 19059.2
- Selling/ General/ Admin Expenses Total
- 2493.7
- Depreciation/ Amortization
- 687
- Other Operating Expenses Total
- 4369.3
- Total Operating Expense
- 17353.6
- Operating Income
- 1705.6
- Net Income Before Taxes
- 1380.5
- Net Income
- 898.6
- Diluted Normalized EPS
- 62.41
- Period
- 2024
- Total Assets
- 16753.1
- Total Liabilities
- 9817.7
- Total Equity
- 6935.4
- Tangible Book Valueper Share Common Eq
- 402.5
- Period
- 2024
- Cashfrom Operating Activities
- 1920.3
- Cashfrom Investing Activities
- -1537.2
- Cashfrom Financing Activities
- -311.1
- Net Changein Cash
- 72
- Period
- 2023
- Total Revenue
- 16612.5
- Selling/ General/ Admin Expenses Total
- 5942.2
- Depreciation/ Amortization
- 614.8
- Other Operating Expenses Total
- 31.4
- Total Operating Expense
- 15163.3
- Operating Income
- 1449.2
- Net Income Before Taxes
- 1143.7
- Net Income
- 819.1
- Diluted Normalized EPS
- 57.78
- Period
- 2023
- Total Assets
- 14427.8
- Total Liabilities
- 8230.4
- Total Equity
- 6197.4
- Tangible Book Valueper Share Common Eq
- 355.09
- Period
- 2023
- Cashfrom Operating Activities
- 1390.5
- Cashfrom Investing Activities
- -870.6
- Cashfrom Financing Activities
- -633
- Net Changein Cash
- -113.1
- Period
- 2022
- Total Revenue
- 14662.6
- Selling/ General/ Admin Expenses Total
- 4882.5
- Depreciation/ Amortization
- 600.1
- Other Operating Expenses Total
- 17.5
- Total Operating Expense
- 12780.1
- Operating Income
- 1882.5
- Net Income Before Taxes
- 1578.1
- Net Income
- 1055.6
- Diluted Normalized EPS
- 59.34
- Period
- 2022
- Total Assets
- 13269.3
- Total Liabilities
- 7646
- Total Equity
- 5623.3
- Tangible Book Valueper Share Common Eq
- 318.22
- Period
- 2022
- Cashfrom Operating Activities
- 1796.6
- Cashfrom Investing Activities
- -847.2
- Cashfrom Financing Activities
- -791.6
- Net Changein Cash
- 157.8
- Period
- 2021
- Total Revenue
- 10560
- Selling/ General/ Admin Expenses Total
- 3663.8
- Depreciation/ Amortization
- 572.5
- Other Operating Expenses Total
- 71.7
- Total Operating Expense
- 9932.2
- Operating Income
- 627.8
- Net Income Before Taxes
- 220.7
- Net Income
- 150.4
- Diluted Normalized EPS
- 8.2
- Period
- 2021
- Total Assets
- 11416.7
- Total Liabilities
- 6814.2
- Total Equity
- 4602.5
- Tangible Book Valueper Share Common Eq
- 288.02
- Period
- 2021
- Cashfrom Operating Activities
- 1256.9
- Cashfrom Investing Activities
- -872.3
- Cashfrom Financing Activities
- -340.1
- Net Changein Cash
- 44.5
- Period
- 2020
- Total Revenue
- 11246.8
- Selling/ General/ Admin Expenses Total
- 4117.4
- Depreciation/ Amortization
- 619.1
- Other Operating Expenses Total
- 39.5
- Total Operating Expense
- 10077.2
- Operating Income
- 1169.6
- Net Income Before Taxes
- 660
- Net Income
- 454.8
- Diluted Normalized EPS
- 23.48
- Period
- 2020
- Total Assets
- 11338.4
- Total Liabilities
- 7999.3
- Total Equity
- 3339.1
- Tangible Book Valueper Share Common Eq
- 211.19
- Period
- 2020
- Cashfrom Operating Activities
- 1292.8
- Cashfrom Investing Activities
- -288.8
- Cashfrom Financing Activities
- -909.5
- Net Changein Cash
- 94.5
- Period
- 2019
- Total Revenue
- 9617.44
- Selling/ General/ Admin Expenses Total
- 3831.59
- Depreciation/ Amortization
- 394.91
- Other Operating Expenses Total
- 52.06
- Total Operating Expense
- 8940.04
- Operating Income
- 677.4
- Net Income Before Taxes
- 373.54
- Net Income
- 236.05
- Diluted Normalized EPS
- 17.02
- Period
- 2019
- Total Assets
- 9183.07
- Total Liabilities
- 5849.6
- Total Equity
- 3333.47
- Tangible Book Valueper Share Common Eq
- 212.2
- Period
- 2019
- Cashfrom Operating Activities
- 904.95
- Cashfrom Investing Activities
- -710.56
- Cashfrom Financing Activities
- -214.51
- Net Changein Cash
- -20.12
- Period
- 2018
- Total Revenue
- 8243.47
- Selling/ General/ Admin Expenses Total
- 3364.7
- Depreciation/ Amortization
- 358.41
- Other Operating Expenses Total
- 42.33
- Total Operating Expense
- 7798.72
- Operating Income
- 444.74
- Net Income Before Taxes
- 171.46
- Net Income
- 117.42
- Diluted Normalized EPS
- 8.81
- Period
- 2018
- Total Assets
- 8612.83
- Total Liabilities
- 5361.32
- Total Equity
- 3251.5
- Tangible Book Valueper Share Common Eq
- 205.88
- Period
- 2018
- Cashfrom Operating Activities
- 536.96
- Cashfrom Investing Activities
- -404.91
- Cashfrom Financing Activities
- -108.5
- Net Changein Cash
- 23.55
- Period
- 2024-06-30
- Total Revenue
- 5085.6
- Selling/ General/ Admin Expenses Total
- 658.1
- Depreciation/ Amortization
- 177.4
- Other Operating Expenses Total
- 1129.4
- Total Operating Expense
- 4587.9
- Operating Income
- 497.7
- Net Income Before Taxes
- 418.5
- Net Income
- 305.2
- Diluted Normalized EPS
- 21.23
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 4943.9
- Selling/ General/ Admin Expenses Total
- 644.9
- Depreciation/ Amortization
- 189.7
- Other Operating Expenses Total
- 1112.8
- Total Operating Expense
- 4493.1
- Operating Income
- 450.8
- Net Income Before Taxes
- 368.2
- Net Income
- 253.8
- Diluted Normalized EPS
- 17.65
- Period
- 2024-03-31
- Total Assets
- 16753.1
- Total Liabilities
- 9817.7
- Total Equity
- 6935.4
- Tangible Book Valueper Share Common Eq
- 402.5
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1920.3
- Cashfrom Investing Activities
- -1537.2
- Cashfrom Financing Activities
- -311.1
- Net Changein Cash
- 72
- Period
- 2023-12-31
- Total Revenue
- 4850.6
- Selling/ General/ Admin Expenses Total
- 612.9
- Depreciation/ Amortization
- 167
- Other Operating Expenses Total
- 1090.9
- Total Operating Expense
- 4403.9
- Operating Income
- 446.7
- Net Income Before Taxes
- 363.3
- Net Income
- 245.3
- Diluted Normalized EPS
- 17.06
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 4846.9
- Selling/ General/ Admin Expenses Total
- 644.1
- Depreciation/ Amortization
- 163.4
- Other Operating Expenses Total
- 1116.8
- Total Operating Expense
- 4380.9
- Operating Income
- 466
- Net Income Before Taxes
- 379
- Net Income
- 232.9
- Diluted Normalized EPS
- 16.11
- Period
- 2023-09-30
- Total Assets
- 15560.9
- Total Liabilities
- 9052.3
- Total Equity
- 6508.6
- Tangible Book Valueper Share Common Eq
- 374.88
- Period
- 2023-09-30
- Period
- 2023-06-30
- Total Revenue
- 4417.8
- Selling/ General/ Admin Expenses Total
- 591.8
- Depreciation/ Amortization
- 166.9
- Other Operating Expenses Total
- 1048.8
- Total Operating Expense
- 4075.7
- Operating Income
- 342.1
- Net Income Before Taxes
- 270
- Net Income
- 166.6
- Diluted Normalized EPS
- 11.59
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 4302.25
- Selling/ General/ Admin Expenses Total
- 590.77
- Depreciation/ Amortization
- 159.22
- Other Operating Expenses Total
- 989.08
- Total Operating Expense
- 3973.33
- Operating Income
- 328.92
- Net Income Before Taxes
- 296.53
- Net Income
- 144.55
- Diluted Normalized EPS
- 10.06
- Period
- 2023-03-31
- Total Assets
- 14427.8
- Total Liabilities
- 8230.4
- Total Equity
- 6197.4
- Tangible Book Valueper Share Common Eq
- 355.09
- Period
- 2023-03-31
- Period
- 2022-12-31
- Total Revenue
- 4263.58
- Selling/ General/ Admin Expenses Total
- 564.77
- Depreciation/ Amortization
- 153.39
- Other Operating Expenses Total
- 977.4
- Total Operating Expense
- 3911.62
- Operating Income
- 351.96
- Net Income Before Taxes
- 265.82
- Net Income
- 153.46
- Diluted Normalized EPS
- 10.67
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Apollo Hospitals Enterprise Technical
Moving Average
SMA
- 5 Day6993.02
- 10 Day6976.55
- 20 Day7038.08
- 50 Day6871.26
- 100 Day6528.9
- 300 Day6334.48
Apollo Hospitals Enterprise Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Apollo Hospitals Enterprise
- 7078.2
- -61.7
- -0.86
- 7319.95
- 4727
- 101773.66
- Max Healthcare Institute
- 965.05
- -3.05
- -0.32
- 1117.05
- 538.95
- 93794.17
- Fortis Healthcare
- 606.85
- -12.35
- -1.99
- 628
- 314
- 45814.64
- Dr. Lal Pathlabs
- 3327.6
- -64.7
- -1.91
- 3645
- 1943.2
- 27689.98
- Narayana Hrudayalaya
- 1285.4
- 16
- 1.26
- 1445.05
- 980
- 26106.45
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Apollo Hospitals Enterprise
- 113.34
- 14.7
- 13.57
- 4.82
- Max Healthcare Institute
- 87.43
- 10.95
- 10.89
- 15.02
- Fortis Healthcare
- 77.22
- 5.89
- 5.07
- 7.63
- Dr. Lal Pathlabs
- 79.55
- 15.39
- 21.32
- 15.99
- Narayana Hrudayalaya
- 32.47
- 8.99
- 23.44
- 9.72
Apollo Hospitals Enterprise Shareholding
Shareholding Pattern
*Promoter pledging: 4.1%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 06-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 03-Aug-24
- ESOP
- 30-May-24
- Audited Results & Final Dividend
- 08-Feb-24
- Quarterly Results & Interim Dividend
- 09-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 30-May-23
- Audited Results & Final Dividend
- 14-Feb-23
- Quarterly Results & Interim Dividend
- 30-Nov-22
- Others
- Meeting Date
- Announced on
- Purpose
- 30-Aug-23
- 03-Aug-23
- AGM
- 31-Aug-21
- 22-Jul-21
- AGM
- 16-Aug-21
- 13-Jul-21
- POM
- 04-May-21
- 06-Apr-21
- POM
- -
- 25-May-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 30-May-24
- 17-Aug-24
- 16-Aug-24
- 10
- 08-Feb-24
- 20-Feb-24
- 20-Feb-24
- 6
- 30-May-23
- 19-Aug-23
- 18-Aug-23
- 9
- 14-Feb-23
- 24-Feb-23
- 24-Feb-23
- 6
- 25-May-22
- -
- 18-Aug-22
- 11.75
- 23-Jun-21
- -
- 18-Aug-21
- 3